Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
Zuranolone for treating moderate to severe postpartum depression Zuranolone Postpartum depression Mental and Behavioural Health 2023 View  |  Download
Zolbetuximab with nab-paclitaxel and gemcitabine for previously untreated metastatic CLDN18.2-positive pancreatic adenocarcinoma Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nab-Paclitaxel (Abraxane; ABI 007; ABI-007) , Zolbetuximab (IMAB362) Pancreatic cancer Gastrointestinal Cancer 2024 View  |  Download
Zolbetuximab for previously untreated advanced gastric or gastro-oesophageal junction adenocarcinoma Zolbetuximab (IMAB362) Gastro-oesophageal junction cancer Gastrointestinal Cancer 2022 View  |  Download
Zilucoplan for treating generalised myasthenia gravis Zilucoplan (RA101495) Myasthenia gravis (MG) Musculoskeletal System 2021 View  |  Download
Zavegepant for treating acute migraine Zavegepant (BHV-3500) Migraine Neurology 2024 View  |  Download
Zanubrutinib plus obinutuzumab for treating relapsed or refractory follicular lymphoma Obinutuzumab (Gazyvaro; RO5072759; GA101; Afutuzumab) , Zanubrutinib (BGB-3111; Brukinsa) Follicular lymphoma Haematological Cancer and Lymphomas 2023 View  |  Download
Zanubrutinib for Waldenstrom's Macroglobulinemia Zanubrutinib (BGB-3111; Brukinsa) Non-Hodgkin lymphoma (NHL) Haematological Cancer and Lymphomas 2018 View  |  Download
Zanubrutinib for treating marginal zone lymphoma Zanubrutinib (BGB-3111; Brukinsa) Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2022 View  |  Download
Zanubrutinib for relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma Zanubrutinib (BGB-3111; Brukinsa) Chronic lymphocytic leukaemia (CLL) , Small lymphocytic lymphoma (SLL) Haematological Cancer and Lymphomas 2022 View  |  Download
Zanubrutinib for previously untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma Zanubrutinib (BGB-3111; Brukinsa) Chronic lymphocytic leukaemia (CLL) , Small lymphocytic lymphoma (SLL) Haematological Cancer and Lymphomas 2022 View  |  Download
1 2 3 117 118
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications